Amanote Research
Register
Sign In
Cell Cytotoxicity of Alpha Interferon Alone and in Combination With Nano Particles Against Breast Cancer Cell Line
International Journal of Biosciences (IJB)
doi 10.12692/ijb/3.5.142-148
Full Text
Open PDF
Abstract
Available in
full text
Date
May 3, 2013
Authors
Unknown
Publisher
International Journal of Biosciences
Related search
Combination of Tumor Necrosis Factor Alpha and Interferon Alpha Induces Apoptotic Cell Death Through a C-Myc–Dependent Pathway in P53 Mutant H226br Non–Small-Cell Lung Cancer Cell Line
Experimental Cell Research
Cell Biology
Cytotoxicity of a Natural Anthraquinone (Aloin) Against Human Breast Cancer Cell Lines With and Without ErbB-2: Topoisomerase II-alpha Coamplification
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Interferon-Alpha Plus Sorafenib Combination Shows Efficacy and Improved Patient Outcome in Renal Cell Cancer
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Cytotoxicity of Standardized Curcuminoids Mixture Against Epithelial Ovarian Cancer Cell Line SKOV-3
Scientia Pharmaceutica
Pharmaceutical Science
An in Vitro Estimation of Cytotoxicity of Fusarium Trichothecene on the Breast Cancer Cell Line
Siberian Journal of Oncology
Cancer Research
Oncology
The Combination of MLN2238 (Ixazomib) With Interferon-Alpha Results in Enhanced Cell Death in Melanoma
Oncotarget
Oncology
NIM811, a Cyclophilin Inhibitor, Exhibits Potent in Vitro Activity Against Hepatitis C Virus Alone or in Combination With Alpha Interferon
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Cytotoxicity of Stem Extracts of Selected Cassia Species Against Hela and Breast Cancer Cell Lines in Vitro
Asian Journal of Pharmaceutical and Clinical Research
Pharmacology
Pharmaceutical Science
The Telomerase Inhibitor Imetelstat Alone, and in Combination With Trastuzumab, Decreases the Cancer Stem Cell Population and Self-Renewal of HER2+ Breast Cancer Cells
Breast Cancer Research and Treatment
Cancer Research
Oncology
